Product catalog antigen listed by alphabetic starting with E
| Items 501 to 600 of 628 total | 7 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00002081-Q01-10 | ERN1 / IRE1 alpha antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002081-Q01-25 | ERN1 / IRE1 alpha antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00030001-Q01-10 | ERO1-like protein alpha / ERO1L antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00030001-Q01-25 | ERO1-like protein alpha / ERO1L antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054206-Q01-10 | ERRFI1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054206-Q01-25 | ERRFI1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002087-Q01-10 | ERVK2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002087-Q01-25 | ERVK2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00030816-Q01-10 | ERVWE1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00030816-Q01-25 | ERVWE1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1000 | Erythopoietin alpha (EPO) antigen | ||||||
| Human | Purified | >98% | CHO cells | 5 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1000X | Erythopoietin alpha (EPO) antigen | ||||||
| Human | Purified | >98% | CHO cells | 50 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1000XC | Erythopoietin alpha (EPO) antigen | ||||||
| Human | Purified | >98% | CHO cells | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1001 | Erythopoietin beta (EPO) antigen | ||||||
| Human | Purified | >99% | CHO cells | 500 U / US$ 405 | |||
| Acris Antibodies GmbH | |||||||
| PA1001X | Erythopoietin beta (EPO) antigen | ||||||
| Human | Purified | >99% | CHO cells | 5000 U / US$ 655 | |||
| Acris Antibodies GmbH | |||||||
| PA1001XC | Erythopoietin beta (EPO) antigen | ||||||
| Human | Purified | >99% | CHO cells | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PBL11965-1 | Erythropoietin (EPO) antigen | ||||||
| Human | >95% | CHO cells | 500 U / --- | ||||
| PBL Biomedical Laboratories | |||||||
| H00002057-Q01-10 | Erythropoietin receptor (EPOR) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002057-Q01-25 | Erythropoietin receptor (EPOR) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011082-Q01-10 | ESM1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011082-Q01-25 | ESM1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002098-P01-10 | Esterase D (ESD) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002098-P01-25 | Esterase D (ESD) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22151F | Esterase D (ESD) antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22151F-50 | Esterase D (ESD) antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| GTX24906 | Estrogen Receptor alpha / ESR1 Peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX25846 | Estrogen Receptor alpha / ESR1 Peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX25847 | Estrogen Receptor alpha / ESR1 Peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00002100-P01-10 | Estrogen Receptor beta / ESR2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002100-P01-25 | Estrogen Receptor beta / ESR2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002100-Q01-10 | Estrogen Receptor beta / ESR2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002100-Q01-25 | Estrogen Receptor beta / ESR2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX25018 | Estrogen Receptor beta / ESR2 Peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00002101-Q01-10 | Estrogen-Related Receptor alpha / ESRRA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002101-Q01-25 | Estrogen-Related Receptor alpha / ESRRA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00080712-Q01-10 | ESX1L antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00080712-Q01-25 | ESX1L antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009283-Q01-10 | ETBR-LP-2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009283-Q01-25 | ETBR-LP-2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055500-P01-10 | ETNK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055500-P01-25 | ETNK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055500-Q01-10 | ETNK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055500-Q01-25 | ETNK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051567-Q01-10 | ETS1-associated protein 2 / TTRAP antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051567-Q01-25 | ETS1-associated protein 2 / TTRAP antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002114-Q01-10 | ETS2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002114-Q01-25 | ETS2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002077-Q01-10 | Ets2 repressor factor (ERF) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002077-Q01-25 | Ets2 repressor factor (ERF) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002115-Q01-10 | ETV1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002115-Q01-25 | ETV1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002117-P01-02 | ETV3 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002117-P01-10 | ETV3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002117-P01-25 | ETV3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002117-Q01-10 | ETV3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002117-Q01-25 | ETV3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002118-P01-10 | ETV4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002118-P01-25 | ETV4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002119-Q01-10 | ETV5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002119-Q01-25 | ETV5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002120-P01-10 | ETV6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002120-P01-25 | ETV6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001979-P01-02 | Eukaryotic translation initiation factor 4E binding protein 2 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002121-Q01-10 | EVC antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002121-Q01-25 | EVC antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002122-Q01-10 | EVI1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002122-Q01-25 | EVI1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002123-P01-10 | EVI2A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002123-P01-25 | EVI2A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002124-Q01-10 | EVI2B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002124-Q01-25 | EVI2B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051466-Q01-10 | EVL antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051466-Q01-25 | EVL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002130-Q01-10 | EWSR1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002130-Q01-25 | EWSR1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1182 | Exendin-4 antigen | ||||||
| Purified | >95% | E. coli | 20 µg / US$ 225 | ||||
| Acris Antibodies GmbH | |||||||
| PA1182X | Exendin-4 antigen | ||||||
| Purified | >95% | E. coli | 0.1 mg / US$ 305 | ||||
| Acris Antibodies GmbH | |||||||
| PA1182XC | Exendin-4 antigen | ||||||
| Purified | >95% | E. coli | 1 mg / US$ 665 | ||||
| Acris Antibodies GmbH | |||||||
| H00009156-Q01-10 | EXO1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009156-Q01-25 | EXO1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055763-Q01-10 | EXOC1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055763-Q01-25 | EXOC1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011336-Q01-10 | EXOC3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011336-Q01-25 | EXOC3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00060412-Q01-10 | EXOC4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00060412-Q01-25 | EXOC4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023265-Q01-10 | EXOC7 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023265-Q01-25 | EXOC7 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051013-P01-02 | EXOSC1 / Exosome component 1 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051013-P01-10 | EXOSC1 / Exosome component 1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051013-P01-25 | EXOSC1 / Exosome component 1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023404-Q01-10 | EXOSC2 / Exosome component 2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023404-Q01-25 | EXOSC2 / Exosome component 2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051010-P01-02 | EXOSC3 / Exosome component 3 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051010-P01-10 | EXOSC3 / Exosome component 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051010-P01-25 | EXOSC3 / Exosome component 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054512-P01-10 | EXOSC4 / Exosome component 4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054512-P01-25 | EXOSC4 / Exosome component 4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00056915-P01-10 | EXOSC5 / Exosome component 5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00056915-P01-25 | EXOSC5 / Exosome component 5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00118460-Q01-10 | EXOSC6 / Exosome component 6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 501 to 600 of 628 total | 7 Page(s): |



